The MRP2/cMOAT Transporter and Arsenic-Glutathione Complex Formation Are Required for Biliary Excretion of Arsenic

This publication has 29 references indexed in Scilit:

• Enzymatic Reduction of Arsenic Compounds in Mammalian Systems: The Rate-Limiting Enzyme of Rabbit Liver Arsenic Biotransformation Is MMA^V Reductase
  Chemical Research in Toxicology, 1999
• Mortality for Certain Diseases in Areas with High Levels of Arsenic in Drinking Water
  Archives of environmental health, 1999
• Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India
  International Journal of Epidemiology, 1998
• URINARY EXCRETION OF ARSENIC METABOLITES AFTER LONG-TERM ORAL ADMINISTRATION OF VARIOUS ARSENIC COMPOUNDS TO RATS
  Journal of Toxicology and Environmental Health, Part A, 1998
• ENZYMATIC METHYLATION OF ARSENIC SPECIES AND OTHER NEW APPROACHES TO ARSENIC TOXICITY
  Annual Review of Pharmacology and Toxicology, 1997
• India's Spreading Health Crisis Draws Global Arsenic Experts
  Science, 1996
• Interindividual variability in the urinary excretion of inorganic arsenic metabolites by C57 BL/6J mice: possible involvement of a thiol/disulfide exchange mechanism
  Toxicology Letters, 1995
• Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status
  British Journal of Cancer, 1995
• Effect of arsenicals on biliary excretion of endogenous glutathione and xenobiotics with glutathione-dependent hepatobiliary transport
  Biochemical Pharmacology, 1991
• Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988